Return On Equity of Dianthus Therapeutics, Inc. /DE/ from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Dianthus Therapeutics, Inc. /DE/ Return On Equity for the quarter ending 30 Sep 2025 was -33%, a 52% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2024 was -24%, a 68% increase from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2023 was -74%, a 184% decline from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2022 was 89%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -33% -11% -52% 01 Jul 2025 30 Sep 2025
Q2 2025 -35% -14% -65% 01 Apr 2025 30 Jun 2025
Q1 2025 -29% +1.2% +4.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -24% +50% +68% 01 Oct 2024 31 Dec 2024
Q3 2024 -22% +772% +97% 01 Jul 2024 30 Sep 2024
Q2 2024 -21% -97% -128% 01 Apr 2024 30 Jun 2024
Q1 2024 -30% -108% -139% 01 Jan 2024 31 Mar 2024
Q4 2023 -74% -163% -184% 01 Oct 2023 31 Dec 2023
Q3 2023 -793% -713% -889% 01 Jul 2023 30 Sep 2023
Q2 2023 76% +41% +116% 01 Apr 2023 30 Jun 2023
Q1 2023 78% +79% 01 Jan 2023 31 Mar 2023
Q4 2022 89% +99% 01 Oct 2022 31 Dec 2022
Q3 2022 -80% -26% -48% 01 Jul 2022 30 Sep 2022
Q2 2022 35% +93% 01 Apr 2022 30 Jun 2022
Q1 2022 -0.57% +63% +99% 01 Jan 2022 31 Mar 2022
Q4 2021 -10% +56% +84% 01 Oct 2021 31 Dec 2021
Q3 2021 -54% -0.7% -1.3% 01 Jul 2021 30 Sep 2021
Q2 2021 -58% -2.4% -4.4% 01 Apr 2021 30 Jun 2021
Q1 2021 -63% -9.4% -17% 01 Jan 2021 31 Mar 2021
Q4 2020 -66% -16% -33% 01 Oct 2020 31 Dec 2020
Q3 2020 -53% -8.2% -18% 01 Jul 2020 30 Sep 2020
Q2 2020 -55% -13% -31% 01 Apr 2020 30 Jun 2020
Q1 2020 -54% -14% -35% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% +4.2% +7.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -45% +37% +45% 01 Jul 2019 30 Sep 2019
Q2 2019 -42% 01 Apr 2019 30 Jun 2019
Q1 2019 -40% 01 Jan 2019 31 Mar 2019
Q4 2018 -54% 01 Oct 2018 31 Dec 2018
Q3 2018 -82% 01 Jul 2018 30 Sep 2018

Dianthus Therapeutics, Inc. /DE/ Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -24% +50% +68% 01 Jan 2024 31 Dec 2024
2023 -74% -163% -184% 01 Jan 2023 31 Dec 2023
2022 89% +99% 01 Jan 2022 31 Dec 2022
2021 -10% +56% +84% 01 Jan 2021 31 Dec 2021
2020 -66% -16% -33% 01 Jan 2020 31 Dec 2020
2019 -50% +4.2% +7.8% 01 Jan 2019 31 Dec 2019
2018 -54% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.